PEAK - Healthpeak Properties, Inc.
NYSE
->
Real Estate
->
REIT—Healthcare Facilities
Denver,
United States
Type: Equity
PEAK price evolution
PEAK
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $169.02 | $113.93 | $160.53 | $117.22 |
| Short term investments | ||||
| Net receivables | $55.82 | $59.09 | $53.47 | $57.7 |
| Inventory | ||||
| Total current assets | $173.46 | $122.56 | $157.25 | $116.94 |
| Long term investments | ||||
| Property, plant & equipment | $13268.52 | $13353.63 | $13331.25 | $13322.85 |
| Goodwill & intangible assets | $314.16 | $339.19 | $364.45 | $391.96 |
| Total noncurrent assets | ||||
| Total investments | $1001.3 | $971.26 | $945.99 | $957.83 |
| Total assets | $15698.85 | $15602.53 | $15603.54 | $15602.29 |
| Current liabilities | ||||
| Accounts payable | $657.2 | $687.65 | $682.76 | $688.99 |
| Deferred revenue | $905.63 | $879.17 | $881.87 | $878.44 |
| Short long term debt | ||||
| Total current liabilities | $863.94 | $892.41 | $887.25 | $896.73 |
| Long term debt | $6876.3 | $6664.41 | $6568.65 | $6453.88 |
| Total noncurrent liabilities | ||||
| Total debt | $7083.04 | $6869.18 | $6773.14 | $6661.61 |
| Total liabilities | $8773.98 | $8569.71 | $8477.89 | $8378.65 |
| Shareholders' equity | ||||
| Retained earnings | -$4621.86 | -$4528.51 | -$4428.42 | -$4316.04 |
| Other shareholder equity | $19.37 | $36.75 | $31.45 | $18.72 |
| Total shareholder equity | $6350.45 | $6457.31 | $6535.06 | $6609.74 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $169.02 | $126.83 | $211.74 | $111.43 |
| Short term investments | ||||
| Net receivables | $55.82 | $53.44 | $48.69 | $42.27 |
| Inventory | ||||
| Total current assets | $173.46 | $125.47 | $206.98 | $86 |
| Long term investments | ||||
| Property, plant & equipment | $13268.52 | $13260.8 | $12901.37 | $11312.11 |
| Goodwill & intangible assets | $314.16 | $418.06 | $519.76 | $519.92 |
| Total noncurrent assets | ||||
| Total investments | $1001.3 | $1081.51 | $864.15 | $642.95 |
| Total assets | $15698.85 | $15771.23 | $15257.52 | $15920.09 |
| Current liabilities | ||||
| Accounts payable | $657.2 | $772.49 | $755.38 | $763.39 |
| Deferred revenue | $905.63 | $844.08 | $789.21 | $774.32 |
| Short long term debt | ||||
| Total current liabilities | $863.94 | $802.12 | $676.57 | $1086 |
| Long term debt | $6876.3 | $6407.52 | $6164.94 | $6297.98 |
| Total noncurrent liabilities | ||||
| Total debt | $7083.04 | $6706.13 | $6374.54 | $6477.87 |
| Total liabilities | $8773.98 | $8482.95 | $8111.41 | $8575.52 |
| Shareholders' equity | ||||
| Retained earnings | -$4621.86 | -$4269.69 | -$4120.77 | -$3976.23 |
| Other shareholder equity | $19.37 | $28.13 | -$3.15 | -$3.69 |
| Total shareholder equity | $6350.45 | $6654.7 | $6515.47 | $6788.35 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $553.65 | $556.24 | $545.43 | $525.68 |
| Cost of revenue | $224.4 | $232.73 | $221.84 | $223.09 |
| Gross Profit | $329.25 | $323.51 | $323.59 | $302.59 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $21.56 | $23.09 | $25.94 | $24.55 |
| Total operating expenses | $219.07 | $207.14 | $226.75 | $203.98 |
| Operating income | $110.18 | $116.37 | $96.84 | $98.61 |
| Income from continuing operations | ||||
| EBIT | $111.89 | $115.51 | $102.11 | $167.22 |
| Income tax expense | -$11.84 | $0.79 | $1.14 | $0.3 |
| Interest expense | $52.78 | $50.51 | $49.07 | $47.96 |
| Net income | ||||
| Net income | $70.94 | $64.21 | $51.9 | $118.95 |
| Income (for common shares) | $70.79 | $64.05 | $51.75 | $117.7 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2061.18 | $1896.18 | $1644.88 | |
| Cost of revenue | $862.99 | $773.28 | $782.54 | |
| Gross Profit | $1198.19 | $1122.9 | $862.33 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $131.03 | $98.3 | $93.24 | |
| Total operating expenses | $853.46 | $807.59 | $708.44 | |
| Operating income | $344.73 | $315.31 | $153.9 | |
| Income from continuing operations | ||||
| EBIT | $668.97 | $660.26 | $622.48 | |
| Income tax expense | -$4.42 | -$3.26 | -$9.42 | |
| Interest expense | $172.94 | $157.98 | $218.34 | |
| Net income | ||||
| Net income | $500.45 | $505.54 | $413.56 | |
| Income (for common shares) | $497.79 | $502.27 | $411.15 | |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $70.94 | $64.21 | $51.9 | $118.95 |
| Operating activities | ||||
| Depreciation | $188.54 | $184.56 | $197.57 | $179.22 |
| Business acquisitions & disposals | -$39.91 | -$20.27 | -$18.57 | -$9.64 |
| Stock-based compensation | $3.51 | $3.43 | $4.25 | $3.29 |
| Total cash flows from operations | $231.25 | $253.26 | $297.82 | $173.92 |
| Investing activities | ||||
| Capital expenditures | -$196.25 | -$212.26 | -$214.16 | -$96.34 |
| Investments | $10.77 | -$5.11 | $22.89 | $156.46 |
| Total cash flows from investing | -$215.67 | -$222.42 | -$195.01 | $56.34 |
| Financing activities | ||||
| Dividends paid | -$164.08 | -$164.01 | -$163.95 | -$164.98 |
| Sale and purchase of stock | $0.5 | $0.02 | -$0.15 | -$6.62 |
| Net borrowings | $202.52 | $93.69 | $120.13 | -$45.57 |
| Total cash flows from financing | $39.52 | -$77.44 | -$59.5 | -$239.88 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $55.1 | -$46.6 | $43.3 | -$9.61 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $306.01 | $500.45 | $505.54 | $413.56 |
| Operating activities | ||||
| Depreciation | $749.9 | $710.57 | $684.29 | $697.14 |
| Business acquisitions & disposals | -$88.39 | $104.84 | -$25.26 | -$433.3 |
| Stock-based compensation | $14.48 | $26.46 | $18.2 | $17.37 |
| Total cash flows from operations | $956.24 | $900.26 | $795.25 | $758.43 |
| Investing activities | ||||
| Capital expenditures | -$719 | -$1100.39 | $194.06 | -$751.96 |
| Investments | $185.01 | $105.24 | $324.59 | $157.2 |
| Total cash flows from investing | -$576.75 | -$876.34 | $531.03 | -$1007.7 |
| Financing activities | ||||
| Dividends paid | -$657.02 | -$648.05 | -$650.08 | -$787.07 |
| Sale and purchase of stock | -$6.25 | $240.26 | -$7.8 | $1058.35 |
| Net borrowings | $370.76 | $320.41 | -$537.96 | $15.79 |
| Total cash flows from financing | -$337.3 | -$116.53 | -$1288.52 | $246.45 |
| Effect of exchange rate | -$0.15 | |||
| Change in cash and equivalents | $42.19 | -$92.61 | $37.76 | -$2.97 |
News
Fundamentals
| Market cap | $9.85B |
|---|---|
| Enterprise value | $16.77B |
| Shares outstanding | 547.16M |
| Revenue | $2.18B |
|---|---|
| EBITDA | $1.25B |
| EBIT | $496.72M |
| Net Income | $306.01M |
| Revenue Q/Q | 5.56% |
| Revenue Y/Y | 5.81% |
| P/E ratio | 32.20 |
|---|---|
| EV/Sales | 7.69 |
| EV/EBITDA | 13.45 |
| EV/EBIT | 33.76 |
| P/S ratio | 4.52 |
| P/B ratio | 1.56 |
| Book/Share | 11.57 |
| Cash/Share | 0.31 |
| EPS | $0.56 |
|---|---|
| ROA | 1.96% |
| ROE | 4.72% |
| Debt/Equity | 1.38 |
|---|---|
| Net debt/EBITDA | 6.90 |
| Current ratio | 0.20 |
| Quick ratio | 0.20 |